ÌÇÐÄvlog´«Ã½

Brazil In-Vitro Diagnostics Market Analysis

The Brazil In Vitro Diagnostics Market size is estimated at USD 2.12 billion in 2024, and is expected to reach USD 2.87 billion by 2029, growing at a CAGR of 6.12% during the forecast period (2024-2029).

The COVID-19 pandemic significantly impacted Brazil in-vitro diagnostics market. For instance, as per a May 2020 update, Brazil's National Health Surveillance Agency (ANVISA) expedited emergency reviews and approvals for medical devices and in-vitro diagnostics (IVDs) related to the COVID-19 pandemic. The agency allowed the emergency use of information from foreign regulatory authorities that participate in the Medical Device Single Audit Program (MDSAP) in place of its own good manufacturing practice inspections.

The major factors fueling the market growth are the high prevalence of chronic diseases and the increasing use of point-of-care diagnostics.

The high prevalence of chronic diseases is a major factor driving the market growth. According to World Population Ageing 2019, the number of people aged above 65 years in 2019 in Brazil region are 19.526 million and is expected to reach 52.026 million by 2050. This increase in geriatric population is expected to increase the prevalence rate of liver cancer in the country as elderly people are more prone to chronic diseases, thus boosting the market. Additionaly, leukemia is the most common cancer in children and has the incidence rates in industrialized countries, followed by developing countries. As per the GLOBOCAN 2020, 11,396 cases of leukemia were identified in Brazil in 2020 including both males and females of all ages. Such a prevalence indicates the rising demand for acute myeloid leukemia treatment in the country.

However, stringent regulations is a major factor hindering the Brazil in-vitro diagnostics market growth.

Brazil In-Vitro Diagnostics Market Trends

This section covers the major market trends shaping the Brazil In Vitro Diagnostics Market according to our research experts:

Molecular Diagnostics Segment is Expected to Witness a Significant Growth

Brazil In-Vitro Diagnostics Industry Segmentation

As per the scope of the report, in vitro diagnostics involve medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases. In the report, a detailed analysis of the in vitro diagnostics market is presented, with specific attention toward diabetes and thalassemia. Brazil in vitro diagnostics market is segmented by test type (clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and other test types), product (instrument, reagent, and other products), usability (disposable IVD devices and reusable IVD devices), application (infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and other applications), and end user (diagnostic laboratories, hospitals and clinics, and other end users). The report offers the value (in USD million) for the above segments.